Rompun 2% 20 mg/ml Solution injectable
Rompun 2% 20 mg/ml Solution injectable
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
Rompun 2% 20 mg/ml Solution injectable
Active substance:
- Xylazine hydrochloride
Target species:
-
Cat
-
Cattle
-
Dog
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Xylazine hydrochloride23.32/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Milkno withdrawal period0 days
-
Meat and offal1day
-
-
-
Intravenous use
-
Cattle
-
Meat and offal1day
-
Milkno withdrawal period0 days
-
-
Horse
-
Meat and offal1day
-
Milkno withdrawal period0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Rompun 2% 25 ml Vial Solution for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 442/07/01/0897
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet